|
|
|
|
 |
|||
|
|||
Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization
MJ Reed, P Puolakkainen, TF Lane, D Dickerson, P Bornstein and EH Sage
Department of Medicine, University of Washington, Seattle.
SPARC and thrombospondin 1 (TSP-1) are secreted glycoproteins expressed by similar types of cells in culture and in tissues. To compare these two proteins in vivo, we analyzed the differential expression of SPARC and TSP-1 during wound repair. Full-thickness incision wounds were made in rats and biopsied at 12 hr-14 days. Antibodies against SPARC revealed an increased proportion of immunoreactive fibroblastic cells at the wound edge at 3 days with maximal numbers at 7 days. In situ hybridization for SPARC produced results consistent with those of immunohistochemistry. With combined immunohistochemistry and in situ hybridization, some of the macrophages at the wound edge expressed SPARC mRNA. In contrast, immunoreactivity for TSP-1 was extracellular; expression at the wound edge was noted at 12 hr and was maximal at 1-2 days. TSP-1 mRNA was found in the thrombus, but not at the wound edge. In conclusion, SPARC and TSP-1 have contrasting roles during wound healing. SPARC expression from the middle through late stages of repair was consistent with its previously proposed functions in remodeling; in contrast, the transient expression of TSP-1 early in repair might facilitate the action of other proteins in recruitment and/or proliferation of cells in the healing wound.
Volume 41,
Issue 10,
pp. 1467-1477,
10/01/1993
Copyright © 1993 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. P. Lillis, L. B. Van Duyn, J. E. Murphy-Ullrich, and D. K. Strickland LDL Receptor-Related Protein 1: Unique Tissue-Specific Functions Revealed by Selective Gene Knockout Studies Physiol Rev, July 1, 2008; 88(3): 887 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Brostjan, K. Gebhardt, B. Gruenberger, V. Steinrueck, H. Zommer, H. Freudenthaler, S. Roka, and T. Gruenberger Neoadjuvant Treatment of Colorectal Cancer with Bevacizumab: The Perioperative Angiogenic Balance Is Sensitive to Systemic Thrombospondin-1 Levels Clin. Cancer Res., April 1, 2008; 14(7): 2065 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Martinek, J. Shahab, J. Sodek, and M. Ringuette Is SPARC an Evolutionarily Conserved Collagen Chaperone? J. Dent. Res., April 1, 2007; 86(4): 296 - 305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Gruber, E. H. Sage, H. J. Norton, S. Funk, J. Ingram, and E. N. Hanley Jr. Targeted Deletion of the SPARC Gene Accelerates Disc Degeneration in the Aging Mouse J. Histochem. Cytochem., September 1, 2005; 53(9): 1131 - 1138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Lefebvre-Lavoie, J. G. Lussier, and C. L. Theoret Profiling of differentially expressed genes in wound margin biopsies of horses using suppression subtractive hybridization Physiol Genomics, July 14, 2005; 22(2): 157 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. N. McLaughlin, M. R. Mazzoni, J. H. Cleator, L. Earls, A. L. Perdigoto, J. D. Brooks, J. A. S. Muldowney III, D. E. Vaughan, and H. E. Hamm Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells J. Biol. Chem., June 10, 2005; 280(23): 22172 - 22180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Puolakkainen, A. D. Bradshaw, R. A. Brekken, M. J. Reed, T. Kyriakides, S. E. Funk, M. D. Gooden, R. B. Vernon, T. N. Wight, P. Bornstein, et al. SPARC-thrombospondin-2-double-null Mice Exhibit Enhanced Cutaneous Wound Healing and Increased Fibrovascular Invasion of Subcutaneous Polyvinyl Alcohol Sponges J. Histochem. Cytochem., May 1, 2005; 53(5): 571 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. McRae, H. M. Johnston, M. Mihm, and P. J. O'Shaughnessy Changes in Mouse Granulosa Cell Gene Expression during Early Luteinization Endocrinology, January 1, 2005; 146(1): 309 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Puolakkainen, R. A. Brekken, S. Muneer, and E. H. Sage Enhanced Growth of Pancreatic Tumors in SPARC-Null Mice Is Associated With Decreased Deposition of Extracellular Matrix and Reduced Tumor Cell Apoptosis Mol. Cancer Res., April 1, 2004; 2(4): 215 - 224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Hormbrey, C. Han, A. Roberts, D. A. McGrouther, and A. L. Harris The Relationship of Human Wound Vascular Endothelial Growth Factor (VEGF) After Breast Cancer Surgery to Circulating VEGF and Angiogenesis Clin. Cancer Res., October 1, 2003; 9(12): 4332 - 4339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Taneda, J. W. Pippin, E. H. Sage, K. L. Hudkins, Y. Takeuchi, W. G. Couser, and C. E. Alpers Amelioration of Diabetic Nephropathy in SPARC-Null Mice J. Am. Soc. Nephrol., April 1, 2003; 14(4): 968 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Puolakkainen, A. D. Bradshaw, T. R. Kyriakides, M. Reed, R. Brekken, T. Wight, P. Bornstein, B. Ratner, and E. H. Sage Compromised Production of Extracellular Matrix in Mice Lacking Secreted Protein, Acidic and Rich in Cysteine (SPARC) Leads to a Reduced Foreign Body Reaction to Implanted Biomaterials Am. J. Pathol., February 1, 2003; 162(2): 627 - 635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schultz, N. Lemke, S. Ge, W. A. Golembieski, and S. A. Rempel Secreted Protein Acidic and Rich in Cysteine Promotes Glioma Invasion and Delays Tumor Growth in Vivo Cancer Res., November 1, 2002; 62(21): 6270 - 6277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Bradshaw, M. J. Reed, and E. H. Sage SPARC-null Mice Exhibit Accelerated Cutaneous Wound Closure J. Histochem. Cytochem., January 1, 2002; 50(1): 1 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakada, A. Yamada, T. Takino, H. Miyamori, T. Takahashi, J. Yamashita, and H. Sato Suppression of Membrane-type 1 Matrix Metalloproteinase (MMP)-mediated MMP-2 Activation and Tumor Invasion by Testican 3 and Its Splicing Variant Gene Product, N-Tes Cancer Res., December 1, 2001; 61(24): 8896 - 8902. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors J. Leukoc. Biol., October 1, 2001; 70(4): 478 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. YANAGISAWA, D.-Q. LI, and A. LJUNGH The N-terminal of thrombospondin-1 is essential for coagulase-negative staphylococcal binding J. Med. Microbiol., August 1, 2001; 50(8): 712 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Drew, H. Liu, J. M. Davidson, C. C. Daugherty, and J. L. Degen Wound-healing defects in mice lacking fibrinogen Blood, June 15, 2001; 97(12): 3691 - 3698. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.C. McParland, S.C. Bell, J.H. Pringle, and D.J. Taylor Regional and cellular localization of osteonectin/SPARC expression in connective tissue and cytotrophoblastic layers of human fetal membranes at term Mol. Hum. Reprod., May 1, 2001; 7(5): 463 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Magee, S. Hagan, P. S. Hiscott, C. M. Sheridan, J. A. Carron, J. McGalliard, and I. Grierson Synthesis of Osteonectin by Human Retinal Pigment Epithelial Cells is Modulated by Cell Density Invest. Ophthalmol. Vis. Sci., August 1, 2000; 41(9): 2707 - 2711. [Abstract] [Full Text]
|
|
|
|
|
|
A. Francki, A. D. Bradshaw, J. A. Bassuk, C. C. Howe, W. G. Couser, and E. H. Sage SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-beta 1 in Mesangial Cells J. Biol. Chem., November 5, 1999; 274(45): 32145 - 32152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Basu, U. Rodeck, G. C. Prendergast, and C. C. Howe Loss of Insulin-like Growth Factor I Receptor-dependent Expression of p107 and Cyclin A in Cells That Lack the Extracellular Matrix Protein Secreted Protein Acidic and Rich in Cysteine Cell Growth Differ., November 1, 1999; 10(11): 721 - 728. [Abstract] [Full Text]
|
|
|
|
|
|
D. B. Stolz, M. A. Ross, H. M. Salem, W. M. Mars, G. K. Michalopoulos, and K. Enomoto Cationic Colloidal Silica Membrane Perturbation as a Means of Examining Changes at the Sinusoidal Surface during Liver Regeneration Am. J. Pathol., November 1, 1999; 155(5): 1487 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. Strandjord, D. K. Madtes, D. J. Weiss, and E. H. Sage Collagen accumulation is decreased in SPARC-null mice with bleomycin-induced pulmonary fibrosis Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L628 - L635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Barnes, R. J. Mitchell, J. J. Kanalas, and V. L. Barnes Differential Expression of Thrombospondin and Cellular Fibronectin During Remodeling in Proliferative Glomerulonephritis J. Histochem. Cytochem., April 1, 1999; 47(4): 533 - 544. [Abstract] [Full Text]
|
|
|
|
|
|
C. Kupprion, K. Motamed, and E. H. Sage SPARC (BM-40, Osteonectin) Inhibits the Mitogenic Effect of Vascular Endothelial Growth Factor on Microvascular Endothelial Cells J. Biol. Chem., November 6, 1998; 273(45): 29635 - 29640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bagavandoss, E. H. Sage, and R. B. Vernon Secreted Protein, Acidic and Rich in Cysteine (SPARC) and Thrombospondin in the Developing Follicle and Corpus Luteum of the Rat J. Histochem. Cytochem., September 1, 1998; 46(9): 1043 - 1050. [Abstract] [Full Text]
|
|
|
|
|
|
Q. Yan, E. H. Sage, and A. E. Hendrickson SPARC Is Expressed by Ganglion Cells and Astrocytes in Bovine Retina J. Histochem. Cytochem., January 1, 1998; 46(1): 3 - 10. [Abstract] [Full Text]
|
|
|
|
|
|
J. A. Soderling, M. J. Reed, A. Corsa, and E. H. Sage Cloning and Expression of Murine SC1, a Gene Product Homologous to SPARC J. Histochem. Cytochem., June 1, 1997; 45(6): 823 - 836. [Abstract] [Full Text] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |